Tag Archives: Pfizers

Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing

CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID antiviral drug & Tollovir™ Phase 2 for hospitalized COVID New York, NY, and Tel Aviv, ISRAEL, Dec. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Gerald Commissiong, CEO of Todos Medical, is scheduled to appear on Yahoo Finance Live with Akiko… Source link

Read More »

3 reasons why the FDA rejected Pfizer’s booster shot for general population

The FDA rejected Pfizer (PFE)/BioNTech’s (BNTX) booster shot recommendation for the general public in order to place greater focus on inoculating the unvaccinated populations and collecting more data on booster shots, Meghan FitzGerald, adjunct associate professor of health policy and management at Columbia University, told Yahoo Finance Live. Though the FDA rejected the booster for the general public by a large margin (16-2), the shot was endorsed unanimously for the elderly and… Source link

Read More »

FDA panel votes against Pfizer’s booster shot

A U.S. Food and Drug Administration (FDA) advisory panel voted Friday against approval of Pfizer (PFE)/BioNTech’s (BNTX) third dose for the U.S. The vote comes after a heated debate in recent weeks over the need for booster or additional shots, which both mRNA companies — Pfizer and Moderna (MRNA) — have advocated for. Dr. Peter Marks, the FDA’s leading expert on vaccines, touched on the controversy in his introductory remarks. “We know that there may be differing opinions of the… Source link

Read More »